A new antibiotic using maggots has been developed by British researchers, which may prove useful in combating drug-resistant bacteria MRSA.
The team from Swansea University in south Wales has created Seraticin, a drug made from the secretions of green bottle fly larvae.
MRSA can Be Eliminated by Avoiding Intravenous Injections
Winchester and Eastleigh Healthcare NHS Trust has successfully managed to reduce MRSA infection in its hospitals by avoiding administering intravenous injections.
Advertisement
They hope it will be turned into a treatment that can be injected, swallowed as a pill or used as an ointment.
Professor Norman Ratcliffe, who led the researchers, said there was more work to be done before the full benefits of the discovery could come to fruition.
"It takes approximately 20 mugs of maggots to yield just one drop of purified Seraticin at present," he said.
"Thus the next stage will be to... produce this chemically on a larger scale."
Source: AFP
RAS/L
"It takes approximately 20 mugs of maggots to yield just one drop of purified Seraticin at present," he said.
"Thus the next stage will be to... produce this chemically on a larger scale."
Source: AFP
RAS/L
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
